from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0998/-

LFCtreatmentdescriptionclass of inhibitor

0.474

Amikacinug/mL Amikacintranslation

0.333

Cap5-10ug/mL Capreomycintranslation

0.060

Rox10-50 ug/mL Roxithromycintranslation

-0.450

SM2-5 ug/mL Streptomycintranslation

0.019

Tet5-10 ug/mL Tetracyclinetranslation

0.585

Rif0.2-5ug/mL Rifampicintranscription

0.095

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.307

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.726

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.281

CPZ10-50 ug/mL Chlorpromazinerespiration

0.237

Clofazimine10-13 ug/mL Clofaziminerespiration

0.368

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.049

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.256

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.803

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.297

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.514

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.534

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.914

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.210

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.409

KCN5-20 ug/mL Potassium cyaniderespiration

0.031

NaN30.2-2 mM Sodium aziderespiration

-0.392

Nigericin50 uM Nigericinrespiration

0.364

TRC10-150 ug/mL Triclosanrespiration

1.066

TRZ10-25 ug/mL Thioridazinerespiration

0.869

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.743

menadione6-10 ug/mL Menadionerespiration

0.276

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.703

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.314

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.161

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.094

NRP_1Non-replicating persistence stage 1dosRassociated

-0.529

Amp0.2mg/mL AmpicillincellWall

-0.011

Cephalexin20-100 ug/mL CephalexincellWall

0.351

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.227

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.334

EMB10-20 ug/mL EthambutolcellWall

0.156

Eta12-40 ug/mL EthionamidecellWall

0.055

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.080

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.059

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.106

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.416

BZA0.12 mg/mL BenzamidearomaticAmides

-0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.430

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.397

H2O24 mM hydrogen peroxideDNAdamaging

0.556

Levo10 ug/mL LevofloxacinDNAdamaging

-1.056

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.444

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.327

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.693

UVUV-irradiationDNAdamaging

1.146

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.286

Antimycin12.5-50 ug/mL Antimycin A?

0.119

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.917

PA8240.2-2 ug/mL PA-824?

1.727

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.171

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.102

Verapamil50 uM Verapamil?

0.106

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.473

methoxatin10-20 ug/mL Methoxatin?